BRAF and thyroid gland carcinoma: Accordingly, a revision of the literature about aggressive TC cases carrying BRAF K601E mutation was performed.<h4>Conclusion</h4>Although rare, this case emphasizes the relevance of considering BRAF K601E mutation in advanced non-PTC thyroid carcinomas, since it can be considered an actionable mutation for target therapies.